Dietary Trans Fatty Acids and Cardiovascular Disease Risk: Past and Present
- 2.1k Downloads
Dietary trans double bond containing fatty acids have been associated with increased risk of cardiovascular disease. There are two main sources of dietary trans fatty acids: meat and dairy fats, and partially hydrogenated fats. Because of a number of factors, including changes in federal labeling requirements for packaged foods, and local bans and grassroots pressure on the use of partially hydrogenated fat, trans fat intake has declined in recent years. Similar to saturated fatty acids, trans fatty acids increase plasma low density lipoprotein (LDL)-cholesterol concentrations. In contrast to saturated fatty acids, trans fatty acids do not increase high density lipoprotein (HDL)-cholesterol concentrations. These differences have been attributed to lipoprotein catabolic rate rather than production rate. When reported, effects of partially hydrogenated fat on glucose homeostasis, C-reactive protein, blood pressure, and LDL oxidation are modest. Although at this time some issues remain unresolved regarding trans fatty acids and CVD risk factors other than plasma lipoprotein concentrations, they should not affect the final dietary recommendation to limit intake.
KeywordsTrans fatty acids Nutrition Diet Public policy Cardiovascular disease Polyunsaturated fatty acids Monounsaturated fatty acids
Compliance with Ethics Guidelines
Conflict of Interest
Alice H. Lichtenstein declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 6.Matthan NR, Welty FK, Barrett PH, Harausz C, Dolnikowski GG, Parks JS, et al. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol. 2004;24(6):1092–7. doi: 10.1161/01.ATV.0000128410.23161.be.PubMedCrossRefGoogle Scholar
- 10.Lefevre M, Mensink RP, Kris-Etherton PM, Petersen B, Smith K, Flickinger BD. Predicted changes in fatty acid intakes, plasma lipids, and cardiovascular disease risk following replacement of trans fatty acid-containing soybean oil with application-appropriate alternatives. Lipids. 2012;47(10):951–62. doi: 10.1007/s11745-012-3705-y.PubMedCentralPubMedCrossRefGoogle Scholar
- 13.Food and Drug Administration. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule. Fed Regist. 2003;133:41433–14506.Google Scholar
- 14.Rahkovsky I, Martinez S, Kuchler F. New food choices free of trans fats better align U.S. diets with health recommendations. Economic Information Bulletin Number 95, USDA. 2012.Google Scholar
- 16.•Angell SY, Cobb LK, Curis CJ, Konty KJ, Silver LD. Change in trans fatty acid content of fast food purchases associated with New York City's restaurant regulation. Annal of Internal Medicine. 2012. This study demonstrated that restricting the use of partially-hydrogenated fat in New York City dramatically decreased the mean trans fatty acid content of food purchased from fast-food restaurants. Google Scholar
- 17.Food and Drug Administration. FDA takes step to further reduce trans fats in processed foods. 2013.Google Scholar
- 18.•Vesper HW, Kuiper HC, Mirel LB, Johnson CL, Pirkle JL. Levels of plasma trans-fatty acids in non-hispanic white adults in the United States in 2000 and 2009. JAMA. 2012;307:562. The findings of this study demonstrate that secular changes in the use of partially-hydrogenated fat in the food supply has an effect on a measurable biomarker, plasma trans fatty acid concentration.PubMedCrossRefGoogle Scholar
- 19.Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, Robins SJ. Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study. Atherosclerosis. 2012;225(2):425–31. doi: 10.1016/j.atherosclerosis.2012.05.030.PubMedCentralPubMedCrossRefGoogle Scholar
- 28.Aronis KN, Joseph RJ, Blackburn GL, Mantzoros C. Trans-fatty acids, insulin resistance/diabetes, and cardiovascular disease risk: should policy decisions be based on observational cohort studies, or should we be waiting for results from randomized placebo-controlled trials? Metab Clin Exp. 2011;60(7):901–5. doi: 10.1016/j.metabol.2011.04.003.PubMedCrossRefGoogle Scholar
- 32.Cuchel M, Schwab US, Jones PJ, Vogel S, Lammi-Keefe C, Li Z, et al. Impact of hydrogenated fat consumption on endogenous cholesterol synthesis and susceptibility of low-density lipoprotein to oxidation in moderately hypercholesterolemic individuals. Metab Clin Exp. 1996;45(2):241–7.PubMedCrossRefGoogle Scholar
- 45.Soares-Miranda L, Stein PK, Imamura F, Sattelmair J, Lemaitre RN, Siscovick DS, et al. Trans-fatty acid consumption and heart rate variability in 2 separate cohorts of older and younger adults. Circ Arrhythm Electrophysiol. 2012;5(4):728–38. doi: 10.1161/CIRCEP.111.966259.PubMedCentralPubMedCrossRefGoogle Scholar
- 49.•Kiage JN, Merrill PD, Robinson CJ, Cao Y, Malik TA, Hundley BC, et al. Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr. 2013;97(5):1121–8. doi: 10.3945/ajcn.112.049064. The data from this study indicated that in a racially and ethnically diverse group of individuals living in the U.S. higher trans fat intake was associated with an increased risk of all-cause mortality.PubMedCentralPubMedCrossRefGoogle Scholar
- 51.Laake I, Pedersen JI, Selmer R, Kirkhus B, Lindman AS, Tverdal A, et al. A prospective study of intake of trans-fatty acids from ruminant fat, partially hydrogenated vegetable oils, and marine oils and mortality from CVD. Br J Nutr. 2012;108(4):743–54. doi: 10.1017/S0007114511005897.PubMedCrossRefGoogle Scholar
- 53.Eckel RH, Jakicic JM, Ard JD, Hubbard VS, de Jesus JM, Lee IM, et al. AHA/acc guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013. doi: 10.1161/01.cir.0000437740.48606.d1.Google Scholar